WHAT IS GESTATIONAL DIABETES; DIABETES IN PREGNANT WOMEN?
Gestational diabetes is an intolerance to glucose with a increase or decrease in the amount of sugar in the blood (glucose). About 7 to 20% of women develop this type of diabetes when they are pregnant. However, it most often
DOES SKIPPING BREAKFAST PUT YOU AT A HIGHER RISK FOR TYPE 2 DIABETES?
It is common to say that breakfast is the most important meal of the day. Moreover, many studies come to explain why it is so important to eat healthy in the morning. A study established the risk German researchers reviewed existing studies
HYPOGLYCEMIA, RECOGNIZING IT AND MANAGING IT
Hypoglycemia is a drop in the level of glucose in the blood, which can cause neurological disorders such as paralysis, double vision or loss of consciousness (blood sugar less than 0.70 g/l). What are the signs of hypoglycemia? Generally, the signs of
DIABNEXT FINALIST OF THE PRIX GALIEN
The pitch competition organized by the Prix Galien distinguishes 8 finalists from more than 50 applications submitted, including DIABNEXT, the hassle-free diabetes monitoring solution. Prix Galien contest 2018 Very honored by this nomination, Laurent NICOLAS states, “We will gradually deploy this technology
DIABNEXT INSTALLS ITS HEADQUARTERS IN PARIS TO DEVELOP ITS TELEMEDICINE OFFER
DIABNEXT is moving its headquarters to 10 rue Treilhard, in the 8th arrondissement of Paris, France in the Morning Monceau space. This implementation makes it possible to maintain close relations with key hospitals for Diabetes in Europe, and in particular
DIABNEXT – Winner of the French Government Diabetes Innovation Award
On Monday, October 16th, at the final round of the Diabetes Innovation Challenge in France, the jury of the French Health Insurance
DIABNEXT selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit
We are thrilled to announce that we are selected as a finalist of the 2017 Lyfebulb-Novo Nordisk Innovation Summit, in Copenhagen, Denmark in November!
DIABNEXT™ wins the AAGEF prize of the FRENCHFOUNDER Start-up Tour!
DIABNEXT™ the next-generation Diabetes care platform using auto-filled health metrics won on Sept. 19th 2017 the French Grandes Écoles Alumni Association prize in the finals of the French Founder Startup Tour 2017. This innovation challenge, co-organized by French Founders &
DIABNEXT™ WINS PM360 TRAILBLAZER 2017 MEDICAL DEVICE COMPANY OF THE YEAR AWARD
DIABNEXT - Our next-generation Diabetes care platform using A.I. and auto-filled health metrics won on Sept. 16th 2018 the Medical Device Company of the Year Trailblazer Gold winner. PM360 is the premier, magazine for marketing decision makers in the pharmaceutical,
DIABNEXT™ ACCELERATES IN THE USA BY OPENING OPERATIONS IN SAN FRANCISCO
DIABNEXT - the next generation Diabetes care platform running the world’s first auto-filled Diabetes logbook - announces the official opening of its Silicon Valley office. San Francisco is DIABNEXT’s second operational office in North America. The firm opened in Boston